Workflow
个体化新抗原治疗疫苗
icon
Search documents
Transgene SA (TRGNF) Discusses TG4050 Phase I Immunological Data in Head and Neck Cancer from SITC Presentation Transcript
Seeking Alpha· 2025-11-14 18:41
PresentationI'd now like to turn the call over to Lucie Larguier. Please go ahead, Lucie.Good morning, and welcome to the Transgene conference call. [Operator Instructions] As a reminder, this call is being recorded, and a replay will be made available on the Transgene website following the event.Lucie LarguierVP & Chief Financial Officer Thank you, Tara, and hello, everyone. Thanks for joining us on today's call, and we will discuss our new TG4050 Phase I immunological data. Today, you will have the opport ...